血漿プロテアーゼC1阻害剤治療の世界市場（～2026年）

• 英文タイトル：Global Plasma Protease C1-inhibitor Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04283
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は血漿プロテアーゼC1阻害剤治療のグローバル市場について調査・分析したレポートです。種類別（C1阻害剤、カリクレイン阻害剤（カルビトール））市場規模、用途別（病院薬局、独立型薬局・アウトレット）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別血漿プロテアーゼC1阻害剤治療の競争状況、市場シェア
・世界の血漿プロテアーゼC1阻害剤治療市場：種類別市場規模 2015年-2020年（C1阻害剤、カリクレイン阻害剤（カルビトール））
・世界の血漿プロテアーゼC1阻害剤治療市場：種類別市場規模予測 2021年-2026年（C1阻害剤、カリクレイン阻害剤（カルビトール））
・世界の血漿プロテアーゼC1阻害剤治療市場：用途別市場規模 2015年-2020年（病院薬局、独立型薬局・アウトレット）
・世界の血漿プロテアーゼC1阻害剤治療市場：用途別市場規模予測 2021年-2026年（病院薬局、独立型薬局・アウトレット）
・北米の血漿プロテアーゼC1阻害剤治療市場分析：米国、カナダ
・ヨーロッパの血漿プロテアーゼC1阻害剤治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの血漿プロテアーゼC1阻害剤治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の血漿プロテアーゼC1阻害剤治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの血漿プロテアーゼC1阻害剤治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Takeda、CSL Limited、Sanquin、Pharming Group N.V.
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

This report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large number of acute HAE patients is increasing the usage of plasma protease C1-inhibitors treatment. Increasing prevalence of rare diseases around the world, promising pipeline drugs and novel therapies, rising investments in innovation of inhibitor drugs and increasing HAE awareness programs are the major drivers of the global plasma protease C1-inhibitors treatment market.
Based on drug class, the market has been segmented into C1-inhibitors (C1-esterase Inhibitor, Recombinant Inhibitor); Kallikrein Inhibitor (Kalbitor); Selective Bradykinin B2 Receptor Antagonist (Firazyr). The drug class market segments have been analyzed based on available approved products, cost-effectiveness, and preference given by the physicians for the treatment of HAE patients.

Market Analysis and Insights: Global Plasma Protease C1-inhibitor Treatment Market
The global Plasma Protease C1-inhibitor Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Plasma Protease C1-inhibitor Treatment Scope and Market Size
Plasma Protease C1-inhibitor Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Plasma Protease C1-inhibitor Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Takeda
CSL Limited
Sanquin
Pharming Group N.V.
…

Market segment by Type, the product can be split into
C1-inhibitors
Kallikrein Inhibitor (Kalbitor)
Market segment by Application, split into
Hospital Pharmacies
Independent Pharmacies and Outlets

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Plasma Protease C1-inhibitor Treatment Revenue
1.4 Market by Type
1.4.1 Global Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 C1-inhibitors
1.4.3 Kallikrein Inhibitor (Kalbitor)
1.5 Market by Application
1.5.1 Global Plasma Protease C1-inhibitor Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Independent Pharmacies and Outlets
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Plasma Protease C1-inhibitor Treatment Market Perspective (2015-2026)
2.2 Global Plasma Protease C1-inhibitor Treatment Growth Trends by Regions
2.2.1 Plasma Protease C1-inhibitor Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Plasma Protease C1-inhibitor Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Plasma Protease C1-inhibitor Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Plasma Protease C1-inhibitor Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Plasma Protease C1-inhibitor Treatment Players by Market Size
3.1.1 Global Top Plasma Protease C1-inhibitor Treatment Players by Revenue (2015-2020)
3.1.2 Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Plasma Protease C1-inhibitor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Plasma Protease C1-inhibitor Treatment Market Concentration Ratio
3.2.1 Global Plasma Protease C1-inhibitor Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Plasma Protease C1-inhibitor Treatment Revenue in 2019
3.3 Plasma Protease C1-inhibitor Treatment Key Players Head office and Area Served
3.4 Key Players Plasma Protease C1-inhibitor Treatment Product Solution and Service
3.5 Date of Enter into Plasma Protease C1-inhibitor Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Plasma Protease C1-inhibitor Treatment Historic Market Size by Type (2015-2020)
4.2 Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Plasma Protease C1-inhibitor Treatment Market Size by Application (2015-2020)
5.2 Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Plasma Protease C1-inhibitor Treatment Market Size (2015-2020)
6.2 Plasma Protease C1-inhibitor Treatment Key Players in North America (2019-2020)
6.3 North America Plasma Protease C1-inhibitor Treatment Market Size by Type (2015-2020)
6.4 North America Plasma Protease C1-inhibitor Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Plasma Protease C1-inhibitor Treatment Market Size (2015-2020)
7.2 Plasma Protease C1-inhibitor Treatment Key Players in Europe (2019-2020)
7.3 Europe Plasma Protease C1-inhibitor Treatment Market Size by Type (2015-2020)
7.4 Europe Plasma Protease C1-inhibitor Treatment Market Size by Application (2015-2020)

8 China
8.1 China Plasma Protease C1-inhibitor Treatment Market Size (2015-2020)
8.2 Plasma Protease C1-inhibitor Treatment Key Players in China (2019-2020)
8.3 China Plasma Protease C1-inhibitor Treatment Market Size by Type (2015-2020)
8.4 China Plasma Protease C1-inhibitor Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Plasma Protease C1-inhibitor Treatment Market Size (2015-2020)
9.2 Plasma Protease C1-inhibitor Treatment Key Players in Japan (2019-2020)
9.3 Japan Plasma Protease C1-inhibitor Treatment Market Size by Type (2015-2020)
9.4 Japan Plasma Protease C1-inhibitor Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size (2015-2020)
10.2 Plasma Protease C1-inhibitor Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size by Application (2015-2020)

11 India
11.1 India Plasma Protease C1-inhibitor Treatment Market Size (2015-2020)
11.2 Plasma Protease C1-inhibitor Treatment Key Players in India (2019-2020)
11.3 India Plasma Protease C1-inhibitor Treatment Market Size by Type (2015-2020)
11.4 India Plasma Protease C1-inhibitor Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Plasma Protease C1-inhibitor Treatment Market Size (2015-2020)
12.2 Plasma Protease C1-inhibitor Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Plasma Protease C1-inhibitor Treatment Market Size by Type (2015-2020)
12.4 Central & South America Plasma Protease C1-inhibitor Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Takeda
13.1.1 Takeda Company Details
13.1.2 Takeda Business Overview
13.1.3 Takeda Plasma Protease C1-inhibitor Treatment Introduction
13.1.4 Takeda Revenue in Plasma Protease C1-inhibitor Treatment Business (2015-2020))
13.1.5 Takeda Recent Development
13.2 CSL Limited
13.2.1 CSL Limited Company Details
13.2.2 CSL Limited Business Overview
13.2.3 CSL Limited Plasma Protease C1-inhibitor Treatment Introduction
13.2.4 CSL Limited Revenue in Plasma Protease C1-inhibitor Treatment Business (2015-2020)
13.2.5 CSL Limited Recent Development
13.3 Sanquin
13.3.1 Sanquin Company Details
13.3.2 Sanquin Business Overview
13.3.3 Sanquin Plasma Protease C1-inhibitor Treatment Introduction
13.3.4 Sanquin Revenue in Plasma Protease C1-inhibitor Treatment Business (2015-2020)
13.3.5 Sanquin Recent Development
13.4 Pharming Group N.V.
13.4.1 Pharming Group N.V. Company Details
13.4.2 Pharming Group N.V. Business Overview
13.4.3 Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Introduction
13.4.4 Pharming Group N.V. Revenue in Plasma Protease C1-inhibitor Treatment Business (2015-2020)
13.4.5 Pharming Group N.V. Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Plasma Protease C1-inhibitor Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Plasma Protease C1-inhibitor Treatment Revenue
Table 3. Ranking of Global Top Plasma Protease C1-inhibitor Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of C1-inhibitors
Table 6. Key Players of Kallikrein Inhibitor (Kalbitor)
Table 7. Global Plasma Protease C1-inhibitor Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Plasma Protease C1-inhibitor Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Plasma Protease C1-inhibitor Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Plasma Protease C1-inhibitor Treatment Market Share by Regions (2015-2020)
Table 11. Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Plasma Protease C1-inhibitor Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Plasma Protease C1-inhibitor Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Plasma Protease C1-inhibitor Treatment Players
Table 18. Global Plasma Protease C1-inhibitor Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Plasma Protease C1-inhibitor Treatment Market Share by Players (2015-2020)
Table 20. Global Top Plasma Protease C1-inhibitor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasma Protease C1-inhibitor Treatment as of 2019)
Table 21. Global Plasma Protease C1-inhibitor Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Plasma Protease C1-inhibitor Treatment Product Solution and Service
Table 24. Date of Enter into Plasma Protease C1-inhibitor Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Plasma Protease C1-inhibitor Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Plasma Protease C1-inhibitor Treatment Market Size Share by Type (2015-2020)
Table 28. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Plasma Protease C1-inhibitor Treatment Market Size Share by Application (2015-2020)
Table 30. Global Plasma Protease C1-inhibitor Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Plasma Protease C1-inhibitor Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Plasma Protease C1-inhibitor Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Plasma Protease C1-inhibitor Treatment Market Share (2019-2020)
Table 34. North America Plasma Protease C1-inhibitor Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Plasma Protease C1-inhibitor Treatment Market Share by Type (2015-2020)
Table 36. North America Plasma Protease C1-inhibitor Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Plasma Protease C1-inhibitor Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Plasma Protease C1-inhibitor Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Plasma Protease C1-inhibitor Treatment Market Share (2019-2020)
Table 40. Europe Plasma Protease C1-inhibitor Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Plasma Protease C1-inhibitor Treatment Market Share by Type (2015-2020)
Table 42. Europe Plasma Protease C1-inhibitor Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Plasma Protease C1-inhibitor Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Plasma Protease C1-inhibitor Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Plasma Protease C1-inhibitor Treatment Market Share (2019-2020)
Table 46. China Plasma Protease C1-inhibitor Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Plasma Protease C1-inhibitor Treatment Market Share by Type (2015-2020)
Table 48. China Plasma Protease C1-inhibitor Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Plasma Protease C1-inhibitor Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Plasma Protease C1-inhibitor Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Plasma Protease C1-inhibitor Treatment Market Share (2019-2020)
Table 52. Japan Plasma Protease C1-inhibitor Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Plasma Protease C1-inhibitor Treatment Market Share by Type (2015-2020)
Table 54. Japan Plasma Protease C1-inhibitor Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Plasma Protease C1-inhibitor Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Plasma Protease C1-inhibitor Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Plasma Protease C1-inhibitor Treatment Market Share (2019-2020)
Table 58. Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Plasma Protease C1-inhibitor Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Plasma Protease C1-inhibitor Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Plasma Protease C1-inhibitor Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Plasma Protease C1-inhibitor Treatment Market Share (2019-2020)
Table 64. India Plasma Protease C1-inhibitor Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Plasma Protease C1-inhibitor Treatment Market Share by Type (2015-2020)
Table 66. India Plasma Protease C1-inhibitor Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Plasma Protease C1-inhibitor Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Plasma Protease C1-inhibitor Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Plasma Protease C1-inhibitor Treatment Market Share (2019-2020)
Table 70. Central & South America Plasma Protease C1-inhibitor Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Plasma Protease C1-inhibitor Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Plasma Protease C1-inhibitor Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Plasma Protease C1-inhibitor Treatment Market Share by Application (2015-2020)
Table 74. Takeda Company Details
Table 75. Takeda Business Overview
Table 76. Takeda Product
Table 77. Takeda Revenue in Plasma Protease C1-inhibitor Treatment Business (2015-2020) (Million US$)
Table 78. Takeda Recent Development
Table 79. CSL Limited Company Details
Table 80. CSL Limited Business Overview
Table 81. CSL Limited Product
Table 82. CSL Limited Revenue in Plasma Protease C1-inhibitor Treatment Business (2015-2020) (Million US$)
Table 83. CSL Limited Recent Development
Table 84. Sanquin Company Details
Table 85. Sanquin Business Overview
Table 86. Sanquin Product
Table 87. Sanquin Revenue in Plasma Protease C1-inhibitor Treatment Business (2015-2020) (Million US$)
Table 88. Sanquin Recent Development
Table 89. Pharming Group N.V. Company Details
Table 90. Pharming Group N.V. Business Overview
Table 91. Pharming Group N.V. Product
Table 92. Pharming Group N.V. Revenue in Plasma Protease C1-inhibitor Treatment Business (2015-2020) (Million US$)
Table 93. Pharming Group N.V. Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasma Protease C1-inhibitor Treatment Market Share by Type: 2020 VS 2026
Figure 2. C1-inhibitors Features
Figure 3. Kallikrein Inhibitor (Kalbitor) Features
Figure 4. Global Plasma Protease C1-inhibitor Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Independent Pharmacies and Outlets Case Studies
Figure 7. Plasma Protease C1-inhibitor Treatment Report Years Considered
Figure 8. Global Plasma Protease C1-inhibitor Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Plasma Protease C1-inhibitor Treatment Market Share by Regions: 2020 VS 2026
Figure 10. Global Plasma Protease C1-inhibitor Treatment Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Plasma Protease C1-inhibitor Treatment Market Share by Players in 2019
Figure 13. Global Top Plasma Protease C1-inhibitor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasma Protease C1-inhibitor Treatment as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Plasma Protease C1-inhibitor Treatment Revenue in 2019
Figure 15. North America Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed

以下、関連資料のご紹介

形質細胞新生物治療の世界市場（～2026年）

Global Plasma Cell Neoplasm Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04280 2020年11月20日 95Pages
当調査資料は形質細胞新生物治療のグローバル市場について調査・分析したレポートです。種類別（放射線療法、化学療法、生物学的製剤/標的療法）市場規模、用途別（病院、専門クリニック、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日...

血漿分画の世界市場（～2026年）

Global Plasma Fraction Market Size, Status and Forecast 2020-2026
MRC2-11QY04282 2020年11月20日 90Pages
当調査資料は血漿分画のグローバル市場について調査・分析したレポートです。種類別（プロテアーゼ阻害剤、プロテアーゼ、線維素溶解タンパク質、凝固因子、抗凝固タンパク質）市場規模、用途別（病院、クリニック、外来外科センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタ...

血漿の世界市場（～2026年）

Global Blood Plasma Market Insights and Forecast to 2026
MRC2-11QY03345 2020年11月20日 119Pages
当調査資料は血漿のグローバル市場について調査・分析したレポートです。種類別（免疫グロブリン、アルブミン、プロテアーゼ阻害剤、凝固因子濃縮物、その他）市場規模、用途別（病院・診療所、研究所、学術機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア...

プラスミノーゲンアクチベーター阻害剤1の世界市場（～2026年）

Global Plasminogen Activator Inhibitor 1 Market Insights and Forecast to 2026
MRC2-11QY13826 2020年11月30日 112Pages
当調査資料はプラスミノーゲンアクチベーター阻害剤1のグローバル市場について調査・分析したレポートです。種類別（SK-216、THR-18、デフィブロチドナトリウム、CT-140、その他）市場規模、用途別（血栓症、急性虚血性脳卒中、動脈血栓症、高血圧症、その他）市場規模、地域別（北米、米国、カナダ、ヨ...

IDO阻害剤の世界市場（～2026年）

Global IDO inhibitor Market Insights and Forecast to 2026
MRC2-11QY01540 2020年11月20日 110Pages
当調査資料はIDO阻害剤のグローバル市場について調査・分析したレポートです。種類別（小分子、細胞療法、非公開）市場規模、用途別（がん、アルツハイマー病、うつ病、白内障）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オ...

血漿成分分離器の世界市場（～2026年）

Global Plasma Component Separator Market Size, Status and Forecast 2020-2026
MRC2-11QY04281 2020年11月20日 93Pages
当調査資料は血漿成分分離器のグローバル市場について調査・分析したレポートです。種類別（膜血漿分離技術、遠心分離、ろ過）市場規模、用途別（病院、診断研究所、製薬およびバイオテクノロジー産業、血液銀行、研究所/学術機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリ...

ヒト血漿由来治療薬の世界市場（～2026年）

Global Human Plasma-Derived Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY12258 2020年11月25日 98Pages
当調査資料はヒト血漿由来治療薬のグローバル市場について調査・分析したレポートです。種類別（アルブミン、免疫グロブリン、凝固因子、プロトロンビン複合体濃縮物、その他）市場規模、用途別（病院、診療所、研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロ...

治療用血漿交換の世界市場（～2026年）

Global Therapeutic Plasma Exchange Market Size, Status and Forecast 2020-2026
MRC2-11QY04839 2020年11月20日 90Pages
当調査資料は治療用血漿交換のグローバル市場について調査・分析したレポートです。種類別（神経障害、腎障害、血液疾患、代謝障害、その他）市場規模、用途別（病院、専門クリニック、外来外科センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、...

多血小板血漿の世界市場（～2026年）

Global Platelet Rich Plasma Market Size, Status and Forecast 2020-2026
MRC2-11QY04292 2020年11月20日 90Pages
当調査資料は多血小板血漿のグローバル市場について調査・分析したレポートです。種類別（純粋PRP、白血球豊富PRP、白血球豊富フィブリン）市場規模、用途別（整形外科、美容整形・皮膚科、眼科、脳神経外科、一般外科、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタ...

プラズマ治療薬の世界市場（～2026年）

Global Plasma Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04284 2020年11月20日 90Pages
当調査資料はプラズマ治療薬のグローバル市場について調査・分析したレポートです。種類別（ヒト血清タンパク質、血漿由来凝固因子、免疫グロブリン、高免疫グロブリン）市場規模、用途別（研究所および機関、病院、独立型血液銀行）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリ...

形質細胞新生物治療の世界市場（～2026年） Plasma cell neoplasms are diseases in which the body makes too many plasma cells. The plasma cells also make an antibody protein, called M protein, that is not needed by the body and does not help fight infection. These antibody proteins build up in the bone marrow and can cause the blood to thicken…
血漿分画の世界市場（～2026年） Blood plasma fractionation refers to the general processes of separating the various components of blood plasma, which in turn is a component of blood obtained through blood fractionation. Increasing awareness about the disease and increasing disposable income are expected to boost the growth of the…
プラスミノーゲンアクチベーター阻害剤1の世界市場（～2026年） Market Analysis and Insights: Global Plasminogen Activator Inhibitor 1 Market The global Plasminogen Activator Inhibitor 1 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Plasminogen Activator Inhibitor 1 Scope and Mar…
IDO阻害剤の世界市場（～2026年） Market Analysis and Insights: Global IDO inhibitor Market The global IDO inhibitor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global IDO inhibitor Scope and Market Size IDO inhibitor market is segmented by Type, and by A…
α1プロテアーゼインヒビターの世界市場（～2026年） Market Analysis and Insights: Global Alpha1-Proteinase Inhibitor Market The global Alpha1-Proteinase Inhibitor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Alpha1-Proteinase Inhibitor Scope and Market Size Alpha1-Pr…